生物技术与制药领域的最新动态
Can Waters Corporation stock resist broad market declines - Inflation Watch & Free Risk Controlled Daily Trade Plans - newser.com
Residence Time: The Impact of Binding Kinetics on Compound-Target Interactions
Agilent (A) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
Will Waters Corporation stock reach all time highs in 2025 - Quarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com
C. Light Named One of Five Selected Projects in the Roche MS Innovation Challenge - Yahoo Finance
Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests - Yahoo Finance
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing - Morningstar
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Yahoo Finance
What momentum indicators show for Agilent Technologies Inc. stock - 2025 Technical Patterns & Weekly Return Optimization Plans - newser.com
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Yahoo Finance
Analyzing recovery setups for Agilent Technologies Inc. investors - Market Trend Report & AI Optimized Trading Strategy Guides - newser.com
3 Reasons to Sell ILMN and 1 Stock to Buy Instead - Finviz
What Thermo Fisher Scientific (TMO)'s FDA Clearance for EXENT System Means for Shareholders - simplywall.st
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status - Morningstar Canada
3 Reasons to Avoid TXG and 1 Stock to Buy Instead - Finviz
Lone Star, Altaris, One Rock Said Among Bidders for Lonza Assets - Bloomberg.com
Freenome and Roche partner on cancer screening technology for ex-US markets - Medical Device Network
Creative Planning Grows Stock Position in Agilent Technologies, Inc. $A - MarketBeat
As Madrigal faces MASH rivals, keeping patients is as critical as finding new ones
Agilent Technologies Inc. stock outlook for YEAR - 2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com